1266例不同类型脑囊尾蚴病患者血清囊虫IgG抗体检测结果分析

来源 :热带病与寄生虫学 | 被引量 : 0次 | 上传用户:lizq06
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察血清囊虫IgG抗体在脑囊尾蚴病临床诊断中的价值。方法对临床确诊的1 266例脑囊尾蚴病患者作血清囊虫IgG抗体检测,将检测结果进行分析。结果 1 266例脑囊尾蚴病患者阳性689例,阳性率54.42%。685例急性期患者中阳性436例,阳性率63.65%;476例慢性期患者中阳性173例,阳性率36.34%;两组间阳性率差异有非常显著性意义(x~2=84.0,P<0.01)。520例急性期单发病灶患者阳性295例,阳性率56.73%,165例多发病灶患者阳性141例,阳性率85.45%,急性期单发灶与多发灶囊虫抗体阳性率差异有统计学意义(x~2=44.69,P<0.01)。385例慢性期单发病灶患者阳性126例,阳性率32.73%,91例多发病灶患者阳性47例,阳性率51.65%,慢性期单发灶与多发灶囊虫抗体阳性率差异有非常性显著意义(x~2=11.46,P<0.01)。混和期(急性期和慢性期病灶同时存在者)98例,阳性73例,阳性率74.49%;弥漫性(满天星病灶)患者7例,均为阳性。结论急性期脑囊尾蚴病抗体阳性率高于慢性期。急性期多发病灶者脑囊尾蚴病抗体阳性率高于急性期单发病灶者,慢性期多发病灶者脑囊尾蚴病抗体阳性率明显高于单发病灶者。 Objective To observe the value of serum cysticercosis IgG antibody in the clinical diagnosis of cerebral cysticercosis. Methods Serum cysticercosis IgG antibody was detected in 1 266 patients with cerebral cysticercosis clinically diagnosed. The detection results were analyzed. Results A total of 1 266 cases of cerebral cysticercosis were positive in 689 cases, the positive rate was 54.42%. The positive rate was 63.65% in 685 cases of acute phase, and 173 cases were positive in 476 cases of chronic phase, the positive rate was 36.34%. The difference between the two groups was significant (x 2 = 84.0, P < 0.01). There were 295 positive cases in 520 cases of acute single lesion, the positive rate was 56.73%. The positive rate of positive rate was 85.45% in 165 cases of multifocal lesion. The positive rates of single antibody and multiple cysticercosis antibodies in acute stage were statistically different x ~ 2 = 44.69, P <0.01). There were 126 positive cases in 385 patients with single chronic lesion, the positive rate was 32.73%. The positive rate was 51.65% in 91 patients with multiple lesions. The positive rates of single antibody and multiple cysticercosis antibodies in chronic phase were significantly different (x ~ 2 = 11.46, P <0.01). In the mixed phase (both acute and chronic lesions coexist), 98 cases were positive and 73 cases were positive, with a positive rate of 74.49%. In diffuse (Gypsophila lesion) patients, 7 cases were positive. Conclusion The positive rate of antibody of cerebral cysticercosis in acute phase is higher than that of chronic phase. The positive rate of antibody of cerebral cysticercosis in patients with multiple acute focal stages was higher than that in acute single stage. The positive rate of antibody of cerebral cysticercosis in patients with chronic multiple stage was significantly higher than that of single lesion.
其他文献
目的:观察吡喃阿霉素(THP)联合化疗治疗老年急性白血病的疗效及其毒副作用.方法:对23例老年急性白血病患者进行THP为主联合化疗,年龄为60岁~81岁(平均67岁),ALL用VTP方案,AML用TA方案.ALL5例,AML17例,CML急淋变1例.结果:CR9例,PR 5例,有效率60.9%.主要毒副作用为骨髓抑制及消化道反应.2例脱发,1例EKG有一过性ST改变.未发现肝肾毒性.结论:THP为
目的:观察重组人白细胞介素-11(rhIL-11)对急性非淋巴细胞白血病患者化疗后血小板减少的预防治疗作用.方法:rhIL-11组于化疗结束后24 h皮下注射rhIL-1125μg.kg-1·-1连用14 d;空白对照组不用药,观察两组血小板减低持续时间、血小板输注量及血小板计数变化情况.结果:rhIL-11能明显缩短急非淋患者化疗后血小板减少持续时间,促进血小板恢复,减少血小板输注量.结论:rh
目的:探讨非清髓性异基因外周造血干细胞移植对慢性粒细胞白血病加速期的治疗效果,以扩大其适用范围.方法:对2例慢性粒细胞白血病加速期患者进行了相关的非清髓性的异基因外
目的:观察和评价DA蛳MA序贯疗法治疗急性髓细胞白血病(AML)M4、M5的疗效,并与以往常用的DA、HA、MA、EA等方案疗效作对比。方法:采用DNR 40 mg·m-2·d-1,连用3 d;Ara蛳C 70
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7
目的:观察沙利度胺联合化疗治疗难治性多发性骨髓瘤的疗效.方法:沙利度胺200mg/d,第1天~第14天,每两周增加200mg/d,直到600 mg/d.化疗选择VAD方案:VCR 0.5 mg泵内注射第1天~第4天,ADM(或EADM)10 mg缓慢静滴,第1天~第4天,地塞米松30 mg/d,口服,第1天~第4天,第9天~第12天,第17天~第20天.结果:5例难治性多发性骨髓瘤3例达部分缓解,
目的注射用兰索拉唑治疗十二指肠溃疡出血疗效及安全性。方法采用随机、盲法、阳性药物、平行对照、多中心的临床试验。试验组:注射用兰索拉唑;对照组:注射用奥美拉唑钠(洛赛
中医学对脑及脑病的认识由来已久,并逐步发展成为一门相对独立的学科.由许沛虎主编、湖北中医学院涂晋文教授主审的的问世(中国医药科技出版社于1998年9月出版)便是其发展史
目的:探讨环孢素A治疗低增生性骨髓增生异常综合征(hypo蛳MDS)的疗效。方法:对5例hypo蛳MDS患者采用环孢素A治疗,定期观察其外周血象和骨髓象,并随诊观察远期疗效。结果:5例
目的:对7例慢性粒细胞白血病合并假性低血糖的病例进行总结,并复习相关文献。方法:对7例慢性粒细胞白血病患者同时采用葡萄糖氧化酶(GOD)法及血糖仪检测空腹血糖,采用直线相